SEPARATION AGREEMENTSeparation Agreement • June 15th, 2020 • Vaxart, Inc. • Biological products, (no disgnostic substances) • California
This Separation Agreement (this “Agreement”) is made and entered into as of June 14, 2020, by and between Wouter Latour, M.D. (“Executive”) and Vaxart, Inc. (the “Company”). The Company and Executive are sometimes collectively referred to herein as the “Parties” and individually as a “Party”.
June 14, 2020 Mr. Andrei Floroiu 385 Oyster Point Boulevard South San Francisco, CA 94080 Dear Andrei,Vaxart, Inc. • June 15th, 2020 • Biological products, (no disgnostic substances) • New York
On behalf of Vaxart, Inc. (the “Company”), I am pleased to provide you with this letter agreement (this “Agreement”) setting forth the terms and conditions of your employment as President and Chief Executive Officer (“CEO”) of the Company, effective as of June 12, 2020 (the “Effective Date”).
